Board Meeting3 Aug 2026, 05:30 pm
Concord Drugs Board Meeting on Aug 10 to Approve Q1 FY27 Results
AI Summary
Concord Drugs Ltd has announced that its Board of Directors will convene on August 10, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. The meeting will cover both standalone and consolidated results. Additionally, the company has closed its trading window for designated persons and their relatives, effective until 48 hours after the financial results are declared, in compliance with its insider trading code.
Key Highlights
- Board meeting scheduled for August 10, 2026.
- To approve unaudited quarterly financial results (Q1 FY27).
- Trading window closed for designated persons.
- Closure is until 48 hours post-results declaration.
Price Impact
More from CONCORD